✦ LIBER ✦

The EGFR as a target for anticancer therapy—focus on cetuximab

✍ Scribed by J Baselga

Book ID: 117657336
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 283 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)00233-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGFR as a Target: Rationale for Therapy

✍ Debra Wujcik 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Targeted therapies for patients with adv

Targeted therapies for patients with advanced colorectal cancer: focus on cetuximab

✍ E. Van Cutsem; R. Labianca; F. Cognetti; J. Tabernero 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 183 KB

Autophagy as a target for anticancer the

Autophagy as a target for anticancer therapy

✍ Janku, Filip; McConkey, David J.; Hong, David S.; Kurzrock, Razelle 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 558 KB

Telomerase as a target for anticancer th

Telomerase as a target for anticancer therapy

✍ Jerry W. Shay 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Telomerase as a possible target for anti

Telomerase as a possible target for anticancer therapy

✍ Chantal Autexier 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Telomeres, the termini of chromosomes, provide essential stability to linear eukaryotic chromosomes. The enzyme telomerase is one mechanism that maintains telomeres, and is activated in 85% of human cancer cells. New studies on peptide nucleic acids (PNAs) that inhibit telomerase have demonstrated t

Tumour vasculature as a target for antic

Tumour vasculature as a target for anticancer therapy

✍ M.M. Eatock; A. Schätzlein; S.B. Kaye 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 218 KB